FindTrial
Sign In

what is the effect of dexmedetomidine on anesthetic drug requirement and post operative pain in thoracotomy patients

Effect of continuous paravertebral dexmedetomidine infusion on intraoperative anesthetic drug requirement and post-operative pain scores after thoracotomy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/01/006565
Enrollment
30
Registered
2016-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients presenting for lung surgery undergoing thoracotomy

Interventions

Intervention1: dexmedetomidine: other group will receive ropivacaine plus dexmedetomidine paravertebral infusion for pain relief Dose- 15ml of 0.75% ropivacaine plus 1mcg/kg of dexmedetomidine bolus f

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 to 70 years, undergoing elective thoracotomy for lung surgeries like wedge resection, lobectomy, pneumonectomy or resection of intrathoracic tumors will be included in the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria 1. Congestive heart failure. 2. NYHA IV 3. Allergy to amide local anesthetics or dexmedetomidine 4. Any contraindication to paravertebral block or patient refusal for paravertebral block.

Design outcomes

Primary

MeasureTime frame
1. Intraoperative anaesthetic drug requirement.Timepoint: 1. Intraoperative anesthetic drug requirement will be measured every 5mins from the start of surgery till the end of surgery.—

Secondary

MeasureTime frame
1. Adequacy of postoperative pain relief (by Visual Analogue Score). 2. Post operative sedation. 3. Incidence of post thoracotomy pain syndrome. Timepoint: 1 and 2 at 1, 2, 3, 4, 8, 12, 16, 20 and 24 hrs. 3rd three months after surgery—

Countries

India

Contacts

Public Contactdr vikas dutta

PGIMER

bhupeshkr@yahoo.com9914209511

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026